These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37716820)

  • 1. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
    Sanders JW; Tang C; Kudchadker RJ; Venkatesan AM; Mok H; Hanania AN; Thames HD; Bruno TL; Starks C; Santiago E; Cunningham M; Frank SJ
    Brachytherapy; 2023; 22(6):822-832. PubMed ID: 37716820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry.
    Sanders JW; Mok H; Hanania AN; Venkatesan AM; Tang C; Bruno TL; Thames HD; Kudchadker RJ; Frank SJ
    Radiother Oncol; 2022 Apr; 169():124-131. PubMed ID: 34921895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
    Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
    Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
    Watanabe K; Katayama N; Katsui K; Matsushita T; Takamoto A; Ihara H; Nasu Y; Takemoto M; Kuroda M; Kanazawa S
    J Radiat Res; 2019 Jul; 60(4):483-489. PubMed ID: 31083713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
    Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
    Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
    Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postimplant Dosimetry of Permanent Prostate Brachytherapy: Comparison of MRI-Only and CT-MRI Fusion-Based Workflows.
    Nosrati R; Wronski M; Tseng CL; Chung H; Pejović-Milić A; Morton G; Stanisz GJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):206-215. PubMed ID: 31627178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning.
    Yan C; Huq MS; Heron DE; Beriwal S; Wynn RB
    Brachytherapy; 2019; 18(3):338-347. PubMed ID: 30655047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.
    Aoki M; Yorozu A; Dokiya T
    Jpn J Radiol; 2009 Nov; 27(9):342-7. PubMed ID: 19943144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live implant dosimetry may be an effective replacement for postimplant computed tomography in localized prostate cancer patients receiving low dose rate brachytherapy.
    Roshan D; Joyce K; Woulfe P; Gorakati PR; Stock R; Sullivan FJ
    Brachytherapy; 2021; 20(4):873-882. PubMed ID: 33840634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
    Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
    Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
    Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
    Katayama N; Takemoto M; Yoshio K; Katsui K; Uesugi T; Nasu Y; Matsushita T; Kaji M; Kumon H; Kanazawa S
    J Radiat Res; 2011; 52(5):680-4. PubMed ID: 21857148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy.
    Crook J; Milosevic M; Catton P; Yeung I; Haycocks T; Tran T; Catton C; McLean M; Panzarella T; Haider MA
    Brachytherapy; 2002; 1(2):66-73. PubMed ID: 15062173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a deep learning-based magnetic resonance imaging only workflow for postimplant dosimetry in I-125 seed brachytherapy for prostate cancer.
    Grigo J; Karius A; Hanspach J; Mücke L; Laun FB; Huang Y; Strnad V; Fietkau R; Bert C; Putz F
    Brachytherapy; 2024; 23(1):96-105. PubMed ID: 38008648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
    Crook J; McLean M; Yeung I; Williams T; Lockwood G
    Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deformable registration of x ray and MRI for postimplant dosimetry in low dose rate prostate brachytherapy.
    Hrinivich WT; Park S; Le Y; Song DY; Lee J
    Med Phys; 2019 Sep; 46(9):3961-3973. PubMed ID: 31215042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.